Circulating tyrosinase and MART-1 mRNA does not independently predict relapse or survival in patients with AJCC stage I-II melanoma

Journal of Investigative Dermatology

Volumn 126, Issue 4, 2006, Pages 849-854

  Schmidt, Henrik ^a   Sorensen, Boe S ^a   Sjoegren, Pia ^a   Christensen, Ib Jarle ^b   Fode, Kirsten ^a   Larsen, Jorn ^a   Nexo, Ebba ^a   Von Der Maase, Hans ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MELAN A; MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; AGING; ARTICLE; BLOOD; BLOOD ANALYSIS; CANCER RELAPSE; CANCER SURVIVAL; FEMALE; FOLLOW UP; GENDER; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR LOCALIZATION; TUMOR VOLUME; ULCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; HUMANS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 33645032573     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700139     Document Type: Article

References (25)

1. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-48
2. Battyani Z, Xerri L, Hassoun J, Bonerandi JJ, Grob JJ (1993) Tyrosinase gene expression in human tissues. Pigment Cell Res 6:400-5
3. Brownbridge GG, Gold J, Edward M, Mackie RM (2001) Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled- polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma. Br J Dermatol 144:279-87
4. Curry BJ, Myers K, Hersey P (1998) Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma. J Clin Oncol 16:1760-9
5. Curry BJ, Myers K, Hersey P (1999) MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases. J Clin Oncol 17:2562-71
6. Garbe C, Leiter U, Ellwanger U, Blaheta HJ, Meier F, Rassner G et al. (2003) Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription- polymerase chain reaction in the follow-up of high-risk melanoma patients. Cancer 97:1737-45
7. Ghossein RA, Coit D, Brennan M, Zhang ZF, Wang Y, Bhattacharya S et al. (1998) Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 4:419-28
8. Hanekom GS, Johnson CA, Kidson SH (1997) An improved and combined reverse transcription-polymerase chain reaction assay for reliable detection of metastatic melanoma cells in peripheral blood. Melanoma Res 7:111-6
9. Hanekom GS, Stubbings HM, Johnson CA, Kidson SH (1999) The detection of circulating melanoma cells correlates with tumour thickness and ulceration but is not predictive of metastasis for patients with primary melanoma. Melanoma Res 9:465-73
10. Hoon DS, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D et al. (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-16
11. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL et al. (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 91:3515-9
12. Keilholz U, Goldin-Lang P, Bechrakis NE, Max N, Letsch A, Schmittel A et al. (2004) Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase- polymerase chain reaction. Clin Cancer Res 10:1605-12
13. Mellado B, Colomer D, Castel T, Munoz M, Carballo E, Galan M et al. (1996) Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 14:2091-7
14. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF et al. (2004) Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 10:8152-62
15. Osella-Abate S, Savoia P, Quaglino P, Fierro MT, Leporati C, Ortoncelli M et al. (2003) Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients. Br J Cancer 89:1457-62
16. Palmieri G, Strazzullo M, Ascierto PA, Satriano SM, Daponte A, Castello G (1999) Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group. J Clin Oncol 17:304-11
17. Proebstle TM, Jiang W, Hogel J, Keilholz U, Weber L, Voit C (2000) Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors. Br J Cancer 82:118-23
18. Quaglino P, Savoia P, Fierro MT, Osella-Abate S, Bernengo MG (2004) Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data. Melanoma Res 14:517-9
19. Schmidt H, Sorensen BS, Fode K, Nexo E, von der MH (2005) Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy. Melanoma Res 15:409-16
20. Schmidt H, Sorensen BS, von der MH, Bang C, Agger R, Hokland M et al. (2002) Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma. Melanoma Res 12:585-92
21. Shaw HM, Beattie CW, McCarthy WH, Milton GW (1985) Late relapse from cutaneous stage I malignant melanoma. Arch Surg 120:1155-9
22. Sorensen BS, Schmidt H, von der Maase H, Straten PT, Nexo E (2000) Quantification of melanoma cell-specific MART-1 mRNA in peripheral blood by a calibrated competitive reverse transcription-PCR. Clin Chem 46:1923-8
23. Tsao H, Cosimi AB, Sober AJ (1997) Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer 79:2361-70
24. Tsao H, Nadiminti U, Sober AJ, Bigby M (2001) A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. Arch Dermatol 137:325-30
25. Voit C, Kron M, Rademaker J, Schwurzer-Voit M, Sterry W, Weber L et al. (2005) Molecular staging in stage II and III melanoma patients and its effect on long-term survival. J Clin Oncol 23:1218-27